Butamirate citrate

CAS: 18109-81-4

Ref. 3D-FB19371

Informação sobre produto

• Nome: Butamirate citrate
• Sinónimos: a-(Ethyl)benzeneacetic acid 2-[2-(diethylamino)ethoxy]ethyl ester2-Hydroxy-1,2,3-propanetricarboxylateAbbott 36581, 18109-81-4, 2-(2-(Diethylamino)ethoxy)ethyl 2-phenylbutanoate 2-hydroxypropane-1,2,3-tricarboxylate, 2-[2-(Diethylamino)Ethoxy]Ethyl 2-Phenylbutanoate 2-Hydroxypropane-1,2,3-Tricarboxylate (1:1), 2-[2-(Diethylamino)ethoxy]ethyl-2-phenylbutyrate citrate (1:1), Abbott 36581, Acodeen, Benzeneacetic Acid, Alpha-Ethyl-, 2-[2-(Diethylamino)Ethoxy]Ethyl Ester, 2-Hydroxy-1,2,3-Propanetricarboxylate (1:1) (Salt), Benzeneacetic acid, α-ethyl-, 2-[2-(diethylamino)ethoxy]ethyl ester, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Butyric acid, 2-phenyl-, 2-[2-(diethylamino)ethoxy]ethyl ester, citrate (1:1), Cough Cut, Ethanol, 2-[2-(diethylamino)ethoxy]-, 2-phenylbutyrate (ester), citrate (1:1), Hh 197, Panatus, Pertix, Sincodeen, Sincodin, Sincodix, Sinecod, Sinecond

Descrição

Butamirate citrate is a pharmacological agent that has been shown to be effective in the treatment of chronic cough, inflammatory bowel disease, and bowel disease. It is an antitussive and antidiarrheal drug with both opioid and non-opioid mechanisms of action. The drug binds to fatty acid receptors in the intestine and lungs, which causes a decrease in smooth muscle tone. This reduces airway resistance, making breathing easier. Butamirate citrate may also work by inhibiting sodium citrate transport across the cell membrane, thereby reducing oxygen transport into cells. This drug can be used to treat symptoms of chronic coughs such as postnasal drip, sinus congestion, sore throat, hoarseness or laryngitis.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 499.55 g/mol
• Fórmula: C₂₄H₃₇NO₁₀
• Pureza: Min. 95%
• Cor/forma: Powder